Hutch News

Hutch News

Stories tagged 'graft versus host disease'

Good News at Fred Hutch

VIDD researchers receive $1.7M grant to study post-transplant infections; Dr. Joshua Roth receives scientific achievement award; Dr. Patrick Mitchell receives microbiology award; Dr. Jesse Bloom named Pew scholar

June 11, 2015 | By Fred Hutch News Service staff

VIDD researchers receive $1.7M grant to study post-transplant infections; Dr. Joshua Roth receives scientific achievement award; Dr. Patrick Mitchell receives microbiology award; Dr. Jesse Bloom named Pew scholar

View story >


‘How do you thank someone for saving your life?’

Stem cell donor, recipient meet each other – and researchers who made transplant possible

April 29, 2015 | By Linda Dahlstrom / Fred Hutch News Service

Leukemia survivor Mark Tose had one burning question for Dr. Mary Flowers: How much of the connection he feels with the donor for the transplant that saved his life is because they were biologically a perfect match — or is something else at play? "It feels like we've known each other forever," he said.

View story >


Life with graft-vs.-host disease: When the transplant is just the beginning

How researchers are trying to combat this common, often debilitating side effect of treatment

April 21, 2015 | By Rachel Tompa / Fred Hutch News Service

Up to 70 percent of transplant recipients, such as Greg Grappone, develop acute graft-vs.-host disease, which crops up within the first few months of treatment, and 40 percent get chronic GVHD, the form that appears more than 100 days post-transplant. As the name implies, the chronic condition can last for years — or a lifetime — and its symptoms range from mildly annoying to disabling to life-threatening.

View story >


'The biggest blessing ever'

Cord blood: a lifesaving option for those in need of a transplant but cannot find a matched donor

April 10, 2015 | By Jenna and Julie Gibson, as told to Susan Keown / Fred Hutch News Service

Jenna Gibson, 12, was diagnosed with acute myeloid leukemia when she was 9 years old. She was treated with a cord blood transplant. She and her mother, Julie, shared their story.

View story >


Gentler treatment effective for many with graft-vs.-host disease

A new study finds halving standard steroid dose treats most acute GVHD just as well; could limit dangerous side effects

Feb. 19, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Up to 70 percent of transplant patients develop acute graft-vs.-host disease. Standard treatment for GVHD, the steroid prednisone, carries its own host of side effects. Fred Hutch's Dr. Marco Mielcarek led a new study testing lower doses of prednisone in patients with acute GVHD -- with promising results.

View story >


Eye on a cure: Bandage contact lenses may heal ocular graft-vs.-host disease symptoms

Small study shows big benefit from contacts that soothe debilitating side effects

Oct. 30, 2014 | JoNel Aleccia / Fred Hutch News Service

Small study shows big benefit from contacts that soothe debilitating side effects

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.